Establishing the value and business model for sustainable eHealth services in Europe

Impact

The dissemination priority for year 2 of the project has mainly been towards the end of the project, on the key ingredients of the business plan. The aim has been to reach key decision makers (such as the eHealth Network), and a wider multi-stakeholder audience though European events. Further targeted outreach is taking place over the summer, and this is expected to continue for at least the rest of 2017. The CEA abstract is to be submitted to an appropriate international medical conference (target: fall 2017).

 

29th August 2016
Keynote presentation at Medical Informatics Europe 2017, Munich.
This presentation to > 200 European health informatics academics and ICT industry participants included insights gained through VALUeHEALTH on the challenges of incentivising interoperability at a European level, and the importance of sustainable business models.

 

25th-26th Oct 2016
VALUeHEALTH workshop at the eHealth Forum, Athens.
This was a meeting by invitation, bringing together representatives of the “eHDSI key partners” and of relevant PHC 34 projects. The aim of the workshop was to understand how the EU collaboration on eHealth supported by Directive 2011/24/EU, the CEF and the new EU Regulatory framework enabling the adoption of cross border digital services, have and are influencing the strategies, roadmaps and business plans of the key partners in terms of proposed post CEF sustainability.

 

9th February 2017
Data quality breakout group (60 persons in that group), as part of a workshop for European hospitals on improving their use and sharing of health data to improve quality of care and expand research.

 

15th March 2017
Meeting with MSEG focus group, Brussels
A very detailed presentation was given to a small focus group comprising members of the MSEG, and representatives from CG Connect and DG Santé. There was detailed discussion about the use cases, the challenges of persuading Member States to extend their commitment to cross-border care and eHealth services, and about the (then draft) recommendations.

 

9th May 2017
Presentation to the eHealth Network, Malta
An initial presentation of the VALUeHEALTH recommendations, which were well received and are planned for more detailed discussion at a future eHealth Network meeting later this year.

 

10th May 2017
Panel contribution at eHealth Week, Malta
A discussion about the challenges of scaling up interoperability, at which the VALUeHEALTH perspective on incentives and its value propositions were presented prior to the open discussion.

 

11th May 2017
Presentation within the EC data portability session at eHealth Week, Malta
A full presentation to a ~ 100 multi-stakeholder audience of the VALUeHEALTH project and of its recommendations.

 

11th May 2017
Exhibition booth for the duration of eHealth Week, Malta
An exhibition booth was staffed full time during the conference, with materials to communicate the VALUeHEALTH project and its results.

 

24th May 2017
Workshop organised by i~HD attended by European hospitals and other stakeholders (ministry, Pharma, ICT), to examine the strategies and incentives for improving data quality (reported in D3.2).

 

28th June 2017
Presentation to CEN TC/251
Presentation of the VALUeHEALTH project use cases, business modelling approach, value propositions and recommendations to CEN TC/251, with other SDOs in attendance.

 

20th July 2017
News article within the EC Digital Single Market section of the web site and communicated widely across Europe within the eHealth, Wellbeing & Ageing Newsletter update - 20/07/2017. This article may be accessed at https://ec.europa.eu/digital-single-market/en/news/creating-sustainable-ehealth-interoperability-valuehealth

 

August 2017
EU Research article on VALUeHEALTH
This article is being distributed to over 50,000 readers in 33 countries. The article may be accessed at https://issuu.com/euresearcher/docs/eur13_digital_magazine_final

 

In addition to the above events, numerous ad hoc discussions have taken place with key actors, such as health insurers, HTA agency representatives, SDO representatives, industry, often 1:1, about the problems in scaling up interoperability across borders, and supporting pan-European continuity of care.